Cortney Caudill
Patrimonio netto: 469 440 $ in data 31/05/2026
Patrimonio netto: 469 440 $ in data 31/05/2026
Cortney Caudill formerly worked at SAMSUNG BIOLOGICS Co., Ltd., as Director-Business Development Technology, Genentech, Inc., as Principal, VaxGen, Inc., as Principal, Baxalta Schweiz AG, as Head-Drug Product External Manufacturing Network from 2014 to 2016, Spyre Therapeutics, Inc., as Chief Product Officer in 2023, and Halozyme Therapeutics, Inc., as Chief Operating Officer & Senior Vice President from 2025 to 2026.
Ms. Caudill received her Masters Business Admin degree from Fordham University and undergraduate degree from The University of Texas at Austin.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/03/2026 | 7.055 ( 0,01% ) | 469 440 $ | 31/05/2026 |
| Società | Posizione | Fine |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Direttore operativo | 30/06/2026 |
| SPYRE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 06/01/2023 |
Baxalta Schweiz AG | Corporate Officer/Principal | 01/02/2016 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes biologic products | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes biologic products | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Fordham University
Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAMSUNG BIOLOGICS Co., Ltd.
SAMSUNG BIOLOGICS Co., Ltd. BiotechnologyHealth Technology Provides biologics development and manufacturing solutions | Health Technology |
Baxalta Schweiz AG |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale